Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00233220 · ClinicalTrials.gov registry record · NA
Blood Pressure Control in African Americans
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 1,039
- Enrollment target
NCT00233220 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 1,039 participants.
The verdict
NCT00233220, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,039 participants
- Enrollment target
Study Summary
The purpose of this study is to test the effectiveness of a multi-component evidence-based intervention that targets both patients and physicians, in improving BP control rates in patients followed in 30 Community/Migrant Health Centers (C/MHCs).
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Multicomponent, multi-level intervention targeted at physicians and patients
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,039 participants |
| Start Date | 2004-09 |
| Est. Completion | 2010-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00233220
The ClinicalTrials.gov registry entry for NCT00233220 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,039 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT00233220 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00233220 about?
NCT00233220 is a clinical study titled "Blood Pressure Control in African Americans". The purpose of this study is to test the effectiveness of a multi-component evidence-based intervention that targets both patients and physicians, in improving BP control rates in patients followed in 30 Community/Migrant Health Centers (C/MHCs).
What is the current status of trial NCT00233220?
This trial is currently completed. It is a NA study. The enrollment target is 1,039 participants. The study started on 2004-09. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00233220?
The interventions under investigation include: Usual Care (BEHAVIORAL), Multicomponent, multi-level intervention targeted at physicians and patients (BEHAVIORAL).
Who is sponsoring clinical trial NCT00233220?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.